华昊中天医药-B（公司全称：北京华昊中天生物医药股份有限公司，股票代码：02563）2026年4月8日发布截至2026年3月31日止的股份变动月报表，披露了公司在本期内完成了非上市股份转H股的全流通安排，注册股本由216,720,857人民币增至364,588,000人民币。
根据公告，华昊中天医药-B在本报告期内完成了147,867,143股非上市股份转换为同等数量的H股。相应地，H股已发行股份总数由216,720,857股增至364,588,000股，非上市股份则由147,867,143股降至零股。公司当月无新增发行、股份回购或注销及库藏股相关事项。
公告显示，公司确认已继续满足香港联交所上市规则要求的公众持股量规定。截至3月底，整体股本规模增至364,588,000股。公司强调将严格遵守香港联交所《上市规则》及其他适用法律法规的要求。
本次公告由公司秘书陈奕斌签署。公司方面表示，有关147,867,143股非上市股份转H股的更多详情，股东及投资者可参阅公司2026年3月30日发布的相关公告。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.